EUVIMEDEUVIMED entdecken
Crossref

Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition

Sarah W Y Lok, Wai Han Yiu, Yixin Zou, Rui Xue, Hongyu Li, Jingyuan Ma, Jiaoyi Chen, Loretta Y Y Chan, Kar Neng Lai, Sydney C W Tang iD

Nephrology Dialysis Transplantation · 2023

DOI: 10.1093/ndt/gfad051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Sarah W Y Lok und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong. Hauptthemen laut MEDLINE: Acute Kidney Injury, Renal Insufficiency, Chronic, Reperfusion Injury, Vascular System Injuries. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Health and Medical Research Fund, Research Grants Council of Hong Kong, Hong Kong Society of Nephrology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thromboembolic events are prevalent in chronic kidney disease (CKD) patients due to increased thrombin generation leading to a hypercoagulable state. We previously demonstrated that inhibition of protease-activated receptor-1 (PAR-1) by vorapaxar reduces kidney fibrosis.

Methods

We used an animal model of unilateral ischemia–reperfusion injury-induced CKD to explore the tubulovascular crosstalk mechanisms of PAR-1 in acute kidney injury (AKI)-to-CKD transition.

Results

During the early phase of AKI, PAR-1-deficient mice exhibited reduced kidney inflammation, vascular injury, and preserved endothelial integrity and capillary permeability. During the transition phase to CKD, PAR-1 deficiency preserved kidney function and diminished tubulointerstitial fibrosis via downregulated transforming growth factor-β/Smad signaling. Maladaptive repair in the microvasculature after AKI further exacerbated focal hypoxia with capillary rarefaction, which was rescued by stabilization of hypoxia-inducible factor and increased tubular vascular endothelial growth factor A in PAR-1-deficient mice. Chronic inflammation was also prevented with reduced kidney infiltration by both M1- and M2-polarized macrophages. In thrombin-induced human dermal microvascular endothelial cells (HDMECs), PAR-1 mediated vascular injury through activation of NF-κB and ERK MAPK pathways. Gene silencing of PAR-1 exerted microvascular protection via a tubulovascular crosstalk mechanism during hypoxia in HDMECs. Finally, pharmacologic blockade of PAR-1 with vorapaxar improved kidney morphology, promoted vascular regenerative capacity, and reduced inflammation and fibrosis depending on the time of initiation.

Conclusions

Our findings elucidate a detrimental role of PAR-1 in vascular dysfunction and profibrotic responses upon tissue injury during AKI-to-CKD transition and provide an attractive therapeutic strategy for post-injury repair in AKI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryRenal Insufficiency, ChronicReperfusion InjuryVascular System InjuriesAnimalsHumansMiceEndothelial CellsFibrosisHypoxiaInflammationKidneyReceptor, PAR-1ThrombinVascular Endothelial Growth Factor ALactonesPyridines

Stichwörter der Autor:innen

AKI-to-CKD transitionHIF stabilizationPAR-1tubulointerstitial fibrosisvorapaxar

Substanzen

Receptor, PAR-1ThrombinVascular Endothelial Growth Factor AvorapaxarLactonesPyridines

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.

ORCID-Profile: Sydney C W Tang

Förderung

  • Health and Medical Research Fund
  • Research Grants Council of Hong Kong
  • Hong Kong Society of Nephrology
  • Hong Kong Kidney Foundation

Zitieren

APA

Lok, S. W. Y., Yiu, W. H., Zou, Y., Xue, R., Li, H., Ma, J., Chen, J., Chan, L. Y. Y., Lai, K. N., & Tang, S. C. W. (2023). Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfad051

Vancouver

Lok SWY, Yiu WH, Zou Y, Xue R, Li H, Ma J, et al. Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfad051

BibTeX
@article{Lok2023,
  author = {Lok, Sarah W Y and Yiu, Wai Han and Zou, Yixin and Xue, Rui and Li, Hongyu and Ma, Jingyuan and Chen, Jiaoyi and Chan, Loretta Y Y and Lai, Kar Neng and Tang, Sydney C W},
  title = {Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  doi = {10.1093/ndt/gfad051}
}
Kostenlos starten →